John R. Sanchez

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Murphy Oil Corporation (United States)(Current)

John R. Sanchez is an author at Murphy Oil Corporation (United States) specializing in tumor-targeting peptides, breast cancer resistance mechanisms, and hormonal cancer therapy.

ORCID

Publications per year

2022–2024

Publications

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Kristin A. Altwegg, Suryavathi Viswanadhapalli, Monica Mann et al. · Cancer Research · 2022 · 27 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia

Janani Ravikrishnan, Daisy Y. Diaz-Rohena, Elizabeth M. Muhowski et al. · Haematologica · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +12

1–2 of 2